News Author: HT Staff Publish date: April 13, 2018
In studying Diamond-Blackfan anemia (DBA), researchers have found evidence to suggest that ribosome levels play a key role in hematopoiesis.
The re...
News Author: HT Staff Publish date: April 12, 2018
New research helps explain why some patients with diffuse large B-cell lymphoma (DLBCL) respond well to immunochemotherapy and others do not.
Resea...
News Author: HT Staff Publish date: April 12, 2018
Preclinical results support clinical testing of an experimental agent in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), according t...
News Author: HT Staff Publish date: April 12, 2018
Researchers have identified novel genes involved in the development of multiple myeloma (MM), according to a paper published in Leukemia.
The team’...
News Author: HT Staff Publish date: April 12, 2018
Palonosetron Hydrochloride Injection, a generic alternative to Aloxi®, is now available in the US.
Fresenius Kabi’s Palonosetron Hydrochloride Inje...
News Author: HT Staff Publish date: April 11, 2018
New research has revealed a link between rare gene variants and survival after hematopoietic stem cell transplant (HSCT).
Researchers performed exo...
News Author: HT Staff Publish date: April 11, 2018
The EZH2 inhibitor tazemetostat demonstrated a “favorable safety profile and antitumor activity” in a phase 1 study, according to researchers. The ...
News Author: HT Staff Publish date: April 11, 2018
The US Food and Drug Administration (FDA) has granted fast track designation to selinexor for the treatment of patients with penta-refractory multiple...
News Author: HT Staff Publish date: April 10, 2018
Health Canada has approved inotuzumab ozogamicin (Besponsa™) as monotherapy for adults with relapsed or refractory, CD22-positive, B-cell precursor ac...
News Author: HT Staff Publish date: April 10, 2018
A 2-drug combination can improve outcomes in patients with mantle cell lymphoma (MCL), according to researchers.
In a phase 2 trial of MCL patients...
News Author: HT Staff Publish date: April 10, 2018
The US Food and Drug Administration (FDA) has granted orphan drug designation to tenalisib for treatment of cutaneous T-cell lymphoma (CTCL).
Tenal...
News Author: HT Staff Publish date: April 10, 2018
The US Food and Drug Administration (FDA) has accepted for priority review the new drug application (NDA) for duvelisib, a dual PI3K delta/gamma in...
News Author: HT Staff Publish date: April 9, 2018
Single-cell analysis has revealed key genetic events in a type of T-cell acute lymphoblastic leukemia (T-ALL), according to researchers.
The team t...
News Author: HT Staff Publish date: April 8, 2018
Researchers believe they may have discovered why iron can sometimes worsen malaria infection.
By studying mice and samples from malaria patients, t...
News Author: HT Staff Publish date: April 7, 2018
New research suggests a family of microRNAs, miR-17-92, plays a key role in chronic graft-versus-host disease (cGVHD).
Researchers found miR-17-92 ...
